No Data
No Data
China Securities Co.,Ltd. is bullish on pharmaceutical companies participating in industry consolidation domestically and actively exploring overseas markets.
Looking ahead to future investment opportunities in the Industry, the bank is Bullish on pharmaceutical companies stabilizing their domestic foundations, actively participating in industry consolidation, managing the rhythm and path externally, and proactively exploring overseas markets.
Did Trump’s "order" cause a collapse in global drug prices? Hong Kong A shares in the pharmaceutical sector reacted quickly!
Trump wants to lower drug prices?
Hong Kong stock market midday review | All three major Indexes rose, with the Tech Index up 1.91%; Apple Suppliers and China-Affiliated Brokerage stocks increased, SUNNY OPTICAL rose over 10%, and China International Capital Corporation rose over 4%.
Network Technology stocks showed mixed performance, with XIAOMI-W down 3.41% and JD-SW up 2.97%; Biotechnology stocks fell for many, with BEIGENE down 7.91% and ASCENTAGE-B down 7.68%; Pharmaceutical stocks generally declined, with 3SBIO down 7.62% and INNOVENT BIO down 6.01%.
The Concept of Innovative Drugs has been severely attacked! Trump suddenly posts: We need to reduce drug prices in the USA by up to 80% immediately!
① The President of the USA, Trump, will sign an executive order on Monday aimed at reducing the prices of USA prescription pharmaceuticals and medications by 30% to 80% immediately; ② The executive order will implement a "most-favored-nation policy," aligning the prices paid in the USA with those of the country with the lowest drug prices in the world; ③ Trump referred to this executive order as "one of the most important executive orders in USA history," expecting it to save trillions of dollars.
Pharmaceutical stocks in Asia fell after Trump announced plans to lower drug prices.
Asian pharmaceutical stocks fell on Monday after President Trump of the USA announced that he would sign an executive order aimed at lowering prescription drug prices. Among Japanese pharmaceutical companies, many of which derive a large portion of their revenue from the USA, Takeda Pharmaceutical's stock fell 5.5%. Otsuka Holdings fell 3.7%, and Chugai Pharmaceutical, a Japanese subsidiary of Roche Holding, fell 6.0%. For the fiscal year ending in March, revenue from the USA accounted for about a third of Takeda's total revenue.
Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs